Avista VP granted restricted and performance shares

Avista Corp vice president Joshua D. DiLuciano reported new equity awards.

Rhea-AI Filing Summary

Avista Corp vice president Joshua D. DiLuciano reported new equity awards. On February 9, 2026, he received 1,756 shares of Common Stock as a restricted share grant at $40.99 per share, bringing his directly held common stock to 12,157.0699 shares.

He was also granted 4,100 performance shares, priced at $40.99, representing potential common stock based on performance goals, with 4,100 derivative securities owned directly after the grant. The restricted shares vest one-third per year over three years, while the performance share cycles run three years, with shares issued only if performance measures are met.

Insider Trade Summary

Grant/Award: 5,856 shares

Grant/Award 2 txns

Insider DiLuciano Joshua D

Role Vice President

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares Grant - 2026	4,100	$40.99	$168K
Grant/Award	Common Stock - Restricted Shares Grant 2026	1,756	$40.99	$72K

Holdings After Transaction: Performance Shares Grant - 2026 — 4,100 contracts (Direct); Common Stock - Restricted Shares Grant 2026 — 12,157.0699 shares (Direct)

Footnotes (3)

1. F1. Restricted Shares vest 1/3 each year over a 3-year period and are payable in Avista Corp. Common Stock at the end of each year in the 3-year period.
2. F2. No conversion price. Shares awarded if performance measure is met.
3. F3. Each performance cycle is 3 years in length. Shares will be issued at the end of each 3-year cycle if performance measure is met.

FAQ

What insider equity awards did Avista Corp (AVA) report for Joshua D. DiLuciano?

Avista Corp reported that vice president Joshua D. DiLuciano received 1,756 restricted common shares and 4,100 performance shares on February 9, 2026. These awards are part of his equity-based compensation and are subject to multi-year vesting and performance conditions.

How do the 2026 restricted share grants for Avista (AVA) vest?

The 2026 restricted share grant of 1,756 common shares vests in thirds over a three-year period. One-third of the shares vest each year and are payable in Avista Corp common stock at the end of each year in the three-year schedule.

What are the terms of the 2026 performance share grant at Avista Corp (AVA)?

The 2026 performance share grant covers 4,100 performance shares with no conversion price. Shares of Avista common stock will be issued only if specified performance measures are met over a three-year performance cycle, at the end of that cycle.

What ownership did Joshua D. DiLuciano report after the restricted share transaction at Avista (AVA)?

After receiving 1,756 restricted common shares, Joshua D. DiLuciano reported beneficial ownership of 12,157.0699 Avista common shares, held directly. This figure reflects his total directly owned common stock following the February 9, 2026 restricted stock grant.

Are the Avista (AVA) 2026 performance shares immediately exercisable or priced?

The 2026 performance shares have no conversion price. Instead, Avista will issue common shares only if defined performance measures are achieved over a three-year cycle. The Form 4 lists the grant using a reference price of $40.99 per share.

Is Joshua D. DiLuciano’s Avista (AVA) ownership direct or indirect after these grants?

Both the restricted shares and performance shares reported are held directly by Joshua D. DiLuciano. The Form 4 lists his ownership form as “D” (direct) for the common stock and for the derivative (performance share) position following the February 9, 2026 grants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 04:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DiLuciano Joshua D

(Last) (First) (Middle)

1411 E MISSION AVE

(Street)

SPOKANE WA 99202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVISTA CORP [ AVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock - Restricted Shares Grant 2026	02/09/2026		A		1,756(1)	A	$40.99	12,157.0699	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Shares Grant - 2026	(2)	02/09/2026		A		4,100		(3)	(3)	Common Stock	4,100	$40.99	4,100	D

Explanation of Responses:

1. Restricted Shares vest 1/3 each year over a 3-year period and are payable in Avista Corp. Common Stock at the end of each year in the 3-year period.

2. No conversion price. Shares awarded if performance measure is met.

3. Each performance cycle is 3 years in length. Shares will be issued at the end of each 3-year cycle if performance measure is met.

	/s/Joshua D. DiLuciano	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.